pindolol has been researched along with guaifenesin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fahr, A; Guitard, P; Matthes, I; Nimmerfall, F; Nüesch, E; Sucker, H | 1 |
| Dorow, P; Felix, R; Schiess, W; Schmutzler, H; Weiss, T | 1 |
1 review(s) available for pindolol and guaifenesin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for pindolol and guaifenesin
| Article | Year |
|---|---|
Influence of propranolol, metoprolol, and pindolol on mucociliary clearance in patients with coronary heart disease.
Topics: Adult; Aged; Bronchi; Cilia; Coronary Disease; Female; Humans; Lung; Male; Metoprolol; Middle Aged; Mucus; Pindolol; Propranolol; Trachea | 1984 |
1 other study(ies) available for pindolol and guaifenesin
| Article | Year |
|---|---|
[Mucus models for investigation of intestinal absorption mechanisms. 3. A mathematical simulation model of drug diffusion through enteral mucus].
Topics: Diffusion; Intestinal Absorption; Models, Biological; Mucus; Pindolol; Software | 1992 |